Publications found:
205
Sort by:
Chronic Bronchitis Treatment Market - 2022-2030
US$ 2,999.00
The Chronic Bronchitis Treatment Market was valued at US$ 5.5 billion in 2022 and is anticipated to reach US$ 7.3 billion by 2030, at a CAGR of 0.037 from 2026 to 2032. The report delivers in-depth in...
January 2026
219 pages
Asthma Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Others), By Mode of Administration (Inhalers, Nebulizers, Oral Medications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Asthma Treatment Market is projected to expand from USD 28.92 Billion in 2025 to USD 37.92 Billion by 2031, achieving a CAGR of 4.62%. This sector encompasses a wide array of pharmacologica...
January 2026
185 pages
Bronchitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Class of Drugs (Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Others), By Type (Acute Bronchitis, Chronic Bronchitis), By End User (Hospital Pharmacies, Retail Pharmacies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Bronchitis Treatment Market is projected to expand from USD 8.57 Billion in 2025 to USD 11.69 Billion by 2031, reflecting a compound annual growth rate of 5.31%. This sector encompasses a r...
January 2026
180 pages
Pharyngitis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Acute Pharyngitis, Chronic Pharyngitis), By Drug Class (Antibiotics, Antiviral Drugs, Corticosteroids, Antifungals, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pharyngitis Treatment Market is expected to rise from USD 2.49 Billion in 2025 to USD 3.27 Billion by 2031 at a CAGR of 4.65%. This market centers on pharmaceutical interventions?such as an...
January 2026
180 pages
Influenza Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Ribavirin, Oseltamivir, Relenza, Peramivir, Influenza Vaccines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Influenza Drugs Market is projected to expand from USD 971.13 Million in 2025 to USD 1416.22 Million by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 6.49%. This sector comprises...
January 2026
180 pages
Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Asthma, COPD, Pneumonia, Tuberculosis, Bronchitis, Others), By Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Cough Suppressants, Nasal Decongestants, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lower Respiratory Tract Therapeutics Market is projected to experience substantial growth, increasing from USD 36.05 Billion in 2025 to USD 58.91 Billion by 2031, reflecting a CAGR of 8.53%...
January 2026
182 pages
Cough Hypersensitivity Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Antitussive Agents, Inhaled Corticosteroids, Short Acting Beta-2 Agonists, Anti-Cholinergics, Antihistamines, Proton Pump Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cough Hypersensitivity Syndrome Treatment Market is projected to grow from USD 4.54 Billion in 2025 to USD 6.34 Billion by 2031, expanding at a CAGR of 5.72%. Cough Hypersensitivity Syndrom...
January 2026
180 pages
Respiratory Syncytial Virus (RSV) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Palivizumab, Ribavirin, Others), By Dosage Form (Oral, Injectable, Others), By Treatment Type (Antiviral Medications, Immune prophylaxis, Others), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Respiratory Syncytial Virus (RSV) Drugs Market is projected to expand from USD 2.04 Billion in 2025 to USD 2.93 Billion by 2031, reflecting a compound annual growth rate of 6.22%. This mark...
January 2026
185 pages
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Others), By Type (Chronic Bronchitis, Emphysema), By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is projected to expand from USD 19.42 Billion in 2025 to USD 29.01 Billion by 2031, reflecting a compound annual growth rate of...
January 2026
180 pages
Lung Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease), By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy), By Drug Class (Corticosteroids, Bronchodilator, Antimicrobial, Alkylating Agents, Mucolytics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Lung Disease Therapeutics Market is projected to expand from USD 104.26 Billion in 2025 to USD 147.31 Billion by 2031, achieving a compound annual growth rate of 5.93%. This sector comprise...
January 2026
185 pages
Respiratory Syncytial Virus (RSV) Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Drug and Vaccines), By End User (Hospitals and Clinics, Ambulatory Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Respiratory Syncytial Virus (RSV) Therapeutics Market is projected to expand from a valuation of USD 2.25 billion in 2025 to USD 3.44 billion by 2031, reflecting a compound annual growth ra...
January 2026
185 pages
Anti-Viral Nasal Spray Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Effective Protection Duration (6 Hours or Less and 6 Hours or More), By Application (Children and Adults), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Anti-Viral Nasal Spray Market is projected to expand from USD 21.34 Billion in 2025 to USD 31.63 Billion by 2031, reflecting a CAGR of 6.78%. This market centers on the creation and distrib...
January 2026
185 pages
Antitussive Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs, Others), By Route of Administration (Inhalational, Oral, Others), By Age Group (Geriatric, Pediatric, Adult), By End-User (Homecare, Hospitals & Specialty Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Antitussive Drugs Market is projected to expand from USD 1.67 Billion in 2025 to USD 2.26 Billion by 2031, registering a CAGR of 5.17%. These pharmaceutical agents are specifically formulat...
January 2026
180 pages
Acute Respiratory Distress Syndrome Treatment Market 2026
US$ 2,999.00
The Acute Respiratory Distress Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dyn...
January 2026
210 pages
The 2027-2032 World Outlook for Asthma Treatments
US$ 1,195.00
This study covers the world outlook for asthma treatments across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for asthma treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
Global Inhalation Therapy Nebulizer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... manufacturers of Inhalation Therapy Nebulizer, with price, sales, revenue and global market share of Inhalation Therapy Nebulizer in 2017 and 2018. Chapter 3, the Inhalation Therapy Nebulizer competitive situation, sales, revenue and global market share ...
January 2026
111 pages
The 2027-2032 World Outlook for Anti-Infective Agents
US$ 1,195.00
This study covers the world outlook for anti-infective agents across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for anti-infective agents. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
The 2027-2032 World Outlook for Asthma Therapeutics
US$ 1,195.00
This study covers the world outlook for asthma therapeutics across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for asthma therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
Global Carbocisteine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... from 44 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Carbocisteine in global market, especially in North America, Europe ... rate by type, application, from 2014 to 2019. Chapter 12, Carbocisteine market forecast, by regions, type and application, with ...
January 2026
93 pages
The 2027-2032 World Outlook for Alpha-1 Antitrypsin Drugs
US$ 1,195.00
This study covers the world outlook for alpha-1 antitrypsin drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Bronchitis Treatments
US$ 1,195.00
This study covers the world outlook for bronchitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Bronchodilators
US$ 1,195.00
This study covers the world outlook for bronchodilators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
